CAR-T Safety and Efficacy Endpoints: A Checklist for Preclinical Development – Genetic Engineering & Biotechnology News
|
CAR–T Safety and Efficacy Endpoints: A Checklist for Preclinical Development
Genetic Engineering & Biotechnology News Chimeric antigen receptor T–cell (CAR-T) therapies have shown great promise for the treatment of certain types of hematological cancers, with two products approved to date by the FDA with more in the pipeline. With this great potential comes a … |
